GB2380129A — Self-emulsifying pharmaceutical compositions
Assigned to GW Pharma Ltd · Expires 2003-04-02 · 23y expired
What this patent protects
The invention relates to pharmaceutical formulations for use in the administration of lipophilic medicaments via mucosal surfaces, which upon hydration form an emulsion containing the lipophilic medicament which is capable of adhering to a mucosal surface and allowing controlled …
USPTO Abstract
The invention relates to pharmaceutical formulations for use in the administration of lipophilic medicaments via mucosal surfaces, which upon hydration form an emulsion containing the lipophilic medicament which is capable of adhering to a mucosal surface and allowing controlled release of the medicament. The invention further provides pharmaceutical formulations which contain, as active ingredients, specific combinations of cannabinoids in pre-defined ratios. The formulation contains a self-emulsifying agent. It is in the form of a gel or compressed tablet for administration to the buccal or sublingual mucosae.
Drugs covered by this patent
- Epidiolex (CANNABIDIOL) · Jazz Pharms Res
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.